CenterBook Partners LP Buys 3,159 Shares of Axon Enterprise, Inc $AXON

CenterBook Partners LP boosted its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 78.0% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 7,208 shares of the biotechnology company’s stock after acquiring an additional 3,159 shares during the quarter. CenterBook Partners LP’s holdings in Axon Enterprise were worth $5,173,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also bought and sold shares of AXON. Stone House Investment Management LLC bought a new stake in Axon Enterprise during the 3rd quarter valued at $29,000. Whipplewood Advisors LLC boosted its position in shares of Axon Enterprise by 192.9% during the second quarter. Whipplewood Advisors LLC now owns 41 shares of the biotechnology company’s stock valued at $34,000 after purchasing an additional 27 shares in the last quarter. Root Financial Partners LLC bought a new stake in shares of Axon Enterprise during the 3rd quarter valued at $34,000. Darwin Wealth Management LLC bought a new stake in Axon Enterprise during the second quarter worth about $37,000. Finally, NewSquare Capital LLC grew its stake in shares of Axon Enterprise by 96.2% in the 2nd quarter. NewSquare Capital LLC now owns 51 shares of the biotechnology company’s stock worth $42,000 after buying an additional 25 shares during the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 1,797 shares of the stock in a transaction on Tuesday, December 2nd. The stock was sold at an average price of $539.23, for a total value of $968,996.31. Following the sale, the insider owned 83,485 shares in the company, valued at $45,017,616.55. This trade represents a 2.11% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Brittany Bagley sold 2,000 shares of the business’s stock in a transaction dated Thursday, December 11th. The shares were sold at an average price of $580.00, for a total transaction of $1,160,000.00. Following the completion of the sale, the chief financial officer directly owned 103,501 shares of the company’s stock, valued at approximately $60,030,580. This trade represents a 1.90% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 48,040 shares of company stock worth $27,249,338 over the last ninety days. Corporate insiders own 4.40% of the company’s stock.

Axon Enterprise Stock Performance

NASDAQ AXON opened at $430.12 on Thursday. Axon Enterprise, Inc has a fifty-two week low of $396.41 and a fifty-two week high of $885.91. The company has a market cap of $33.94 billion, a P/E ratio of 136.11, a P/E/G ratio of 13.01 and a beta of 1.48. The company has a debt-to-equity ratio of 0.57, a quick ratio of 2.89 and a current ratio of 3.12. The business’s 50 day moving average price is $550.04 and its 200-day moving average price is $641.48.

Analysts Set New Price Targets

AXON has been the subject of a number of analyst reports. Wall Street Zen lowered shares of Axon Enterprise from a “hold” rating to a “sell” rating in a research note on Saturday, November 8th. Royal Bank Of Canada initiated coverage on Axon Enterprise in a report on Monday, November 17th. They issued an “outperform” rating and a $860.00 target price on the stock. Weiss Ratings reissued a “hold (c-)” rating on shares of Axon Enterprise in a research report on Monday, December 29th. Morgan Stanley reduced their target price on shares of Axon Enterprise from $760.00 to $713.00 and set an “overweight” rating for the company in a report on Wednesday, December 17th. Finally, UBS Group lowered their price objective on Axon Enterprise from $840.00 to $610.00 and set a “neutral” rating on the stock in a research report on Wednesday, November 5th. Fifteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Axon Enterprise currently has a consensus rating of “Moderate Buy” and an average target price of $805.71.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.